Viewing Study NCT04488705


Ignite Creation Date: 2025-12-25 @ 3:32 AM
Ignite Modification Date: 2026-02-08 @ 11:10 PM
Study NCT ID: NCT04488705
Status: COMPLETED
Last Update Posted: 2021-05-21
First Post: 2020-07-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD002 in Healthy Subjects
Sponsor: Enterprise Therapeutics Ltd
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cystic fibrosis View